Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Mingqun Lin Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogen Emerg Microbes Infect 2026 15 2645860
Lisha Deng Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice Vaccine 2026 92 129118
Bandar Alosaimi An epitope-based peptide vaccine targeting influenza a elicits robust immune responses and induces protection in a mouse model Sci Rep 2026
Yujun Liu An Oral Vaccine Derived from Attenuated Salmonella Producing Murine Cytomegalovirus M24 Protein Induces Successful Antiviral Immune Responses in Mice Vaccines (Basel) 2026 14
Arianna De Chiara Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination Mol Ther Nucleic Acids 2026 37 102851
Ying Feng A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses Mol Ther 2026 34 1597-1615
Lin Liu A modular three in one mucosal vaccine against three antigenic clusters of ACE2 using sarbecoviruses NPJ Vaccines 2026 11
Anne Senz RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma J Immunother Cancer 2026 14
Laura Seclì Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma model J Immunother Cancer 2025 13
Zhuolin Yang A mosaic H3 subtype live attenuated influenza vaccine elicits broad immune responses to influenza a viruses Vaccine 2025 65 127776